First in human Phase 1
Partial epigenetic reprogramming
ER-100 is testing a local OSK based approach in optic neuropathies. This is an early safety and tolerability study, not proof of systemic age reversal.
Life Biosciences · ER-100FRONTIER BIOLOGY · SOURCE LINKED VIEW
Track the frontier without turning possibility into proof.
Peptide Readiness now separates the wider biological frontier from the molecule readiness database. That lets researchers and decision makers see where the science is moving while keeping clinical, regulatory and access claims disciplined.
Editorial boundary. This page is research intelligence. It is not a treatment recommendation, an age reversal claim, a dosing protocol or an endorsement of any unlicensed product.
PLATFORM SIGNALS
Four useful lenses on emerging biology.
Stage labels describe the maturity of the source proposition, not the likelihood of a future product. Every claim must be read with its source, endpoint, jurisdiction and limitations.
Established research platform
Induced pluripotent stem cells
The Yamanaka work showed that defined factors could reprogramme differentiated mouse cells. The result is foundational platform science, not a clinical treatment claim.
Cell · Yamanaka 2006Enabling method
AI assisted discovery
Machine learning can help generate hypotheses, prioritise candidates and find patterns across literature and datasets. Outputs still require source review, laboratory work and clinical validation.
Nature · AlphaFold2 studyPreclinical and translational
Cellular clearance and repair
Senolytic, mitochondrial and repair approaches remain a broad research field. Each named intervention needs its own target, model, endpoint and human evidence record.
Method · evidence standardsAI ASSISTED INTELLIGENCE
Faster discovery. The same burden of proof.
AI can accelerate search, comparison, change detection and first-pass synthesis across a large evidence base. It cannot be the sole authority for a regulatory status, a clinical conclusion or a lawful access statement.
- 01Machine assisted retrieval and clustering
- 02Human verification against the primary source
- 03Versioned record with uncertainty preserved